Clinical Trials Directory

Trials / Completed

CompletedNCT03286088

Mitral Valve Regurgitation Quantification From 3D Color Doppler Ultrasound - Standard of Care Data Collection

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Philips Electronics Nederland B.V. acting through Philips CTO organization · Industry
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The study primarily aims to collect standard of care clinical data in a wide spectrum of simple to complex mitral valve regurgitation (MVR) cases to validate a post-processing stand-alone software prototype (QFlow), developed by Philips Research Paris (Medisys). Investigator does not intervene in the care of the patient, but simply collects standard of care images and measurements that are needed for the validation of the investigational software.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTTransEsophageal Echocardiography and TransEsophageal Echocardiographyimaging as standard practice
DIAGNOSTIC_TESTCardiac Magnetics Resonanceimaging as standard practice
DIAGNOSTIC_TESTMitraClipimaging as standard practice

Timeline

Start date
2017-08-22
Primary completion
2019-07-31
Completion
2019-12-31
First posted
2017-09-18
Last updated
2021-10-27

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT03286088. Inclusion in this directory is not an endorsement.